首页 | 本学科首页   官方微博 | 高级检索  
检索        

基于网络药理学对乌药汤治疗原发性痛经作用机制的研究
引用本文:袁胜男,袁冲,毛志海,余兵,杨艳芳,郝晨阳,刘袁青,吴和珍.基于网络药理学对乌药汤治疗原发性痛经作用机制的研究[J].中国医院药学杂志,2020,40(10):1116-1121.
作者姓名:袁胜男  袁冲  毛志海  余兵  杨艳芳  郝晨阳  刘袁青  吴和珍
作者单位:1. 湖北中医药大学药学院, 湖北 武汉 430065;2. 真奥金银花药业有限公司, 湖北 咸宁 437000;3. 中药资源与中药化学湖北省重点实验室, 湖北 武汉 430061;4. 老年病中药新产品湖北省协同创新中心, 湖北 武汉 430065
基金项目:国家自然科学基金项目(编号:31570343)
摘    要:目的:利用网络药理学方法探讨乌药汤治疗原发性痛经的作用机制。方法:借助中药系统药理学分析平台(TCMSP)筛选乌药汤的活性成分;通过Pharmmapper数据库筛选活性成分潜在靶点基因,使用GeneCards数据库得到原发性痛经相关基因靶点;将活性成分的潜在靶点基因与原发性痛经相关基因进行比对,得到乌药汤治疗原发性痛经的潜在靶点基因;使用KOBAS3.0数据库对靶点基因功能(gene ontology,GO)和KEGG通路进行分析,得到乌药汤治疗原发性痛经的重要调节通路;采用Cytoscape3.6.1软件构建“成分-靶点-通路”网络;将筛选得到的主要活性成分和关键靶点进行分子对接验证。结果:从乌药汤中共筛选出菜蓟苦素、金圣草(黄)素、异黄檀素、甘草素f等31个活性成分,涉及包括ESR1、CASP3、MMP9、HRAS在内的23个基因靶点,影响了内分泌抵抗(Endocrine resistance)、雌激素受体信号传导通路(Estrogen signaling pathway)和催乳激素信号通路(Prolactin signaling pathway)等95条与原发性痛经相关的信号通路。分子对接结果显示,筛选得到的主要活性成分与关键靶点有较强结合,其中菜蓟苦素(cynaropicrin)和关键靶点的结合能力与阳性药接近。结论:本研究通过构建“成分-靶点-通路”网络图,揭示了乌药汤能通过多成分、多靶点、多通路发挥药效,为进一步阐释乌药汤治疗原发性痛经作用机制提供了科学依据。

关 键 词:网络药理学  乌药汤  原发性痛经  作用机制  分子对接
收稿时间:2019-08-18

Study on the mechanism of Wuyao Decoction in treating primary dysmenorrhea based on network pharmacology
YUAN Sheng-nan,YUAN Chong,MAO Zhi-hai,YU Bing,YANG Yan-fang,HAO Chen-yang,LIU Yuan-qing,WU He-zhen.Study on the mechanism of Wuyao Decoction in treating primary dysmenorrhea based on network pharmacology[J].Chinese Journal of Hospital Pharmacy,2020,40(10):1116-1121.
Authors:YUAN Sheng-nan  YUAN Chong  MAO Zhi-hai  YU Bing  YANG Yan-fang  HAO Chen-yang  LIU Yuan-qing  WU He-zhen
Institution:1. School of Pharmacy, Hubei University of Chinese Medicine, Hubei Wuhan 430065, China;2. Zhenao Jinyinhua pharmaceutical co. LTD, Hubei Xianning 437000, China;3. Key laboratory of Traditional Chinese Medicine of Resources and Chemistry Hubei Province, Hubei Wuhan 430061, China;4. Collaborative Innovation Center of TCM of New Products for Geriatrics Hubei Province, Hubei Wuhan 430065, China
Abstract:OBJECTIVE To explore the mechanism of Wuyao decoction in treating primary dysmenorrhea by network pharmacology.METHODS The traditional Chinese medicine system pharmacology analysis platform (TCMSP) was used to screen the active components of Wuyao decoction.The potential target genes of active ingredients were screened by Pharmmapper database.The target genes related to primary dysmenorrhea were obtained by GeneCards database.Then the potential targets of active ingredients were compared with the genes related to primary dysmenorrhea,and the potential target genes of Wuyao decoction for primary dysmenorrhea was obtained.KOBAS3.0 database was used to analyze the gene ontology (GO) and KEGG pathway,and the important regulatory pathway of wuyao decoction in the treatment of primary dysmenorrhea was obtained.The "components-targets-pathways" network was constructed by using Cytoscape 3.6.1 software.The main active components and key targets were screened for molecular docking verification.RESULTS A total of 31 active components including Escherichia coli,Dioscorea zingiberensis,Isoflavone,and Glycyrrhizin f were selected from Wuyao decoction,involving 23 target genes including ESR1,CASP3,MMP9 and HRAS.And 95 signal pathways related to primary dysmenorrhea,such as Endocrine resistance,Estrogen signaling pathway and Prolactin signaling pathway were found after analyzing.Molecular docking results showed that the main active components were strongly bound to key targets,and the binding ability of cynaropicrin and key targets was close to that of positive drugs.CONCLUSION By constructing the "components-target genes-pathways" network,the study reveals the characteristics of Wuyao decoction exerting its effects through multi-components,multi-targets and multi-pathways,which provides a scientific basis for further elucidation of Wu Yao decoction in the treatment of primary dysmenorrhea.
Keywords:network pharmacology  Wuyao decoction  primary dysmenorrhea  mechanism of action  molecular docking  
本文献已被 维普 等数据库收录!
点击此处可从《中国医院药学杂志》浏览原始摘要信息
点击此处可从《中国医院药学杂志》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号